$KVUE – Trend Shift in Motion? - $20.50 PTLooking at NYSE:KVUE to break through the $17.04's going into Next Week's trading session were we expect it to find some resistance with $20.50 being previous support.
NYSE:KVUE is showing early signs of a potential trend reversal after a strong rebound off the $14.02 lows, and buyers are now eyeing the $17.04 level as the next key breakout zone.
The stock has broken above short-term structure but still sits just under a major descending resistance trendline — a level that has capped price action since early 2024. A breakout above that $17 region could trigger momentum toward $20.50, which previously acted as strong support before the summer breakdown.
📊 Technical Breakdown
Support Levels: $16.46 → $15.50 → $14.02 (confirmed base)
Resistance Levels: $17.04 → $18.80 → $20.50
Structure: W-bottom reversal forming after multi-month downtrend
Momentum: RSI pivoting bullish from midrange; volume expanding on rebounds
Outlook: A close above $17.04 may confirm the first higher high in months
The path to $20.50 aligns with the larger symmetrical retracement pattern, suggesting potential for a sustained recovery if momentum continues into next week’s sessions.
🧠 Market Context
Kenvue ( NYSE:KVUE ), the consumer health spin-off from Johnson & Johnson, has faced steady pressure since its IPO but is now gaining traction on institutional rotation back into defensive consumer names.
The company’s brand portfolio (Tylenol, Band-Aid, Listerine, Neutrogena) continues to provide stable cash flow — and if sentiment improves, KVUE could rejoin the $20–$22 range seen earlier this year.
💡 My Plan
Entry Zone: $16.50–$17.00 on confirmation
Primary Target: $20.50
Stretch Target: $21.50+ if channel breaks and momentum continues
Invalidation: Close below $15.80 = retest of $14 support likely
Momentum continuation is key — look for volume confirmation as it retests the $17.04 region to validate breakout strength.
#KVUE #Kenvue #Stock #MyMIWallet
